Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Diabetes Reviews
  4. Volume 21, Issue 7
  5. Article
Volume 21, Issue 7
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Background

The increasing specialization and dispersion of healthcare systems have led to a shortage of resources to address comorbidities. Patients with coexisting mental and physical conditions are disadvantaged, as medical providers often only focus on the patient's mental illness while neglecting their physical needs, resulting in poorer health outcomes.

Objective

This study aimed to shed light on the systemic flaws in healthcare systems that contribute to suboptimal health outcomes in individuals with comorbid diseases, including depression and diabetes. This paper also discusses the clinical and economic benefits of collaborative methods for diagnosing and treating depressive disorders in primary care settings.

Methods

A comprehensive literature review of the relationship between depression and diabetes was conducted. The outcomes of the literature review were carefully analyzed. Several databases were searched using keywords such as “diabetes,” “depression,” “comorbidity,” “prevalence,” “epidemiology,” and “risk factors” using Google Scholar and PubMed as search engines. The review and research papers written between 1961 and 2023 were our main focus.

Results

This study revealed improved depressive symptoms and better blood sugar and blood pressure control. Additionally, individuals with comorbid depression and diabetes have higher direct and secondary medical costs. Antidepressants and psychological interventions are equally effective in treating depressive symptoms in patients with diabetes, although they have conflicting effects on glycemic control. For individuals with comorbid diabetes and depression, clear care pathways, including a multidisciplinary team, are essential for achieving the best medical and mental health outcomes.

Conclusion

Coordinated healthcare solutions are necessary to reduce the burden of illness and improve therapeutic outcomes. Numerous pathophysiological mechanisms interact with one another and may support the comorbidities of T2DM, and depressive disorders could exacerbate the course of both diseases.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998288090240509105717
2024-05-24
2025-05-09

  • From This Site

    /content/journals/cdr/10.2174/0115733998288090240509105717
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MoultonC.D. PickupJ.C. IsmailK. The link between depression and diabetes: The search for shared mechanisms.Lancet Diabetes Endocrinol.20153646147110.1016/S2213‑8587(15)00134‑5
     [Google Scholar]
  2. AndersonR.J. FreedlandK.E. ClouseR.E. LustmanP.J. The prevalence of comorbid depression in adults with diabetes: A meta-analysis.Diabetes Care20012461069107810.2337/diacare.24.6.1069 11375373
     [Google Scholar]
  3. KesslerR.C. AmmingerG.P. GaxiolaA.S. AlonsoJ. LeeS. UstünT.B. Age of onset of mental disorders: A review of recent literature.Curr. Opin. Psychiatry200720435936410.1097/YCO.0b013e32816ebc8c 17551351
     [Google Scholar]
  4. SnoekF.J. BremmerM.A. HermannsN. Constructs of depression and distress in diabetes: Time for an appraisal.Lancet Diabetes Endocrinol.20153645046010.1016/S2213‑8587(15)00135‑7 25995123
     [Google Scholar]
  5. MessinaR. IommiM. RucciP. Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study.Acta Diabetol.20225919510410.1007/s00592‑021‑01791‑x 34495396
     [Google Scholar]
  6. WalP. WadhwaS. WalA. Current Practices in Insulin and Vaccine Storag.Pharmacophore20191037081
     [Google Scholar]
  7. VijR. AroraS. A systematic review on diabetic retinopathy detection using deep learning techniques.Arch. Comput. Methods Eng.20233032211225610.1007/s11831‑022‑09862‑0
     [Google Scholar]
  8. EgedeL.E. Disease-focused or integrated treatment: Diabetes and depression.Med. Clin. North Am.200690462764610.1016/j.mcna.2006.04.001 16843766
     [Google Scholar]
  9. GredenJ.F. Physical symptoms of depression: Unmet needs.J. Clin. Psychiatry200364S7511 12755646
     [Google Scholar]
  10. HafeezA. DangelW.J. OstroffS.M. The state of health in Pakistan and its provinces and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019.Lancet Glob. Health2023112e22943
     [Google Scholar]
  11. ÜstünT.B. MateosA.J.L. ChatterjiS. MathersC. MurrayC.J.L. Global burden of depressive disorders in the year 2000.Br. J. Psychiatry2004184538639210.1192/bjp.184.5.386 15123501
     [Google Scholar]
  12. LinE.H.B. KorffM.V. AlonsoJ. Mental disorders among persons with diabetes—Results from the World Mental Health Surveys.J. Psychosom. Res.200865657158010.1016/j.jpsychores.2008.06.007 19027447
     [Google Scholar]
  13. KesslerR.C. BerglundP. DemlerO. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R).JAMA20032892330953105
     [Google Scholar]
  14. AlonsoJ. AngermeyerM.C. BernertS. Prevalence of mental disorders in Europe: Results from the European study of the epidemiology of mental disorders (ESEMeD) project.Acta Psychiatr. Scand. Suppl.20044204202127 15128384
     [Google Scholar]
  15. DemyttenaereK. BruffaertsR. VillaP.J. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.JAMA2004291212581259010.1001/jama.291.21.2581 15173149
     [Google Scholar]
  16. MichaudC.M. MurrayC.J. BloomB.R. Burden of disease--implications for future research.JAMA2001285553553910.1001/jama.285.5.535 11176854
     [Google Scholar]
  17. BaldwinM.L. Reducing the costs of work-related musculoskeletal disorders: Targeting strategies to chronic disability cases.J. Electromyogr. Kinesiol.20041413341
     [Google Scholar]
  18. MercedesB.P. da SilvaN.E. CarregaroR.L. Economic burden of depression in Brazil: A cost-of-illness study based on productivity losses and healthcare costs between 2010 to to 2018.Expert Rev. Pharmacoecon. Outcomes Res.2023232181189
     [Google Scholar]
  19. LiC. FordE.S. StrineT.W. MokdadA.H. Prevalence of depression among U.S. adults with diabetes: Findings from the 2006 behavioral risk factor surveillance system.Diabetes Care200831110510710.2337/dc07‑1154 17934145
     [Google Scholar]
  20. AsgharS. HussainA. AliS.M.K. KhanA.K.A. MagnussonA. Prevalence of depression and diabetes: A population‐based study from rural Bangladesh.Diabet. Med.200724887287710.1111/j.1464‑5491.2007.02136.x 17403122
     [Google Scholar]
  21. KoganS.M. BrodyG.H. CrawleyC. LoganP. MurryV.M. Correlates of elevated depressive symptoms among rural African American adults with type 2 diabetes.Ethn. Dis.2007171106112 17274218
     [Google Scholar]
  22. GaryT.L. CrumR.M. PatrickC.L. FordD. BrancatiF.L. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes.Diabetes Care2000231232910.2337/diacare.23.1.23 10857963
     [Google Scholar]
  23. AliS. StoneM.A. PetersJ.L. DaviesM.J. KhuntiK. The prevalence of co‐morbid depression in adults with Type 2 diabetes: A systematic review and meta‐analysis.Diabet. Med.200623111165117310.1111/j.1464‑5491.2006.01943.x 17054590
     [Google Scholar]
  24. FisherL. GlasgowR.E. StryckerL.A. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes.Diabetes Care20103351034103610.2337/dc09‑2175 20150291
     [Google Scholar]
  25. FisherL. MullanJ.T. AreanP. GlasgowR.E. HesslerD. MasharaniU. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses.Diabetes Care2010331232810.2337/dc09‑1238 19837786
     [Google Scholar]
  26. NouwenA. WinkleyK. TwiskJ. Type 2 diabetes mellitus as a risk factor for the onset of depression: A systematic review and meta-analysis.Diabetologia201053122480248610.1007/s00125‑010‑1874‑x 20711716
     [Google Scholar]
  27. PeyrotM. RubinR.R. Persistence of depressive symptoms in diabetic adults.Diabetes Care199922344845210.2337/diacare.22.3.448 10097927
     [Google Scholar]
  28. LustmanP.J. GriffithL.S. ClouseR.E. Depression in adults with diabetes. Results of 5-yr follow-up study.Diabetes Care198811860561210.2337/diacare.11.8.605 3219966
     [Google Scholar]
  29. ReynoldsK.A. HelgesonV.S. Children with diabetes compared to peers: Depressed? Distressed? A meta-analytic review.Ann. Behav. Med.2011421294110.1007/s12160‑011‑9262‑4 21445720
     [Google Scholar]
  30. MezukB. EatonW.W. AlbrechtS. GoldenS.H. Depression and type 2 diabetes over the lifespan: A meta-analysis.Diabetes Care200831122383239010.2337/dc08‑0985 19033418
     [Google Scholar]
  31. GoldenS.H. LazoM. CarnethonM. Examining a bidirectional association between depressive symptoms and diabetes.JAMA2008299232751275910.1001/jama.299.23.2751 18560002
     [Google Scholar]
  32. KnolM.J. TwiskJ.W.R. BeekmanA.T.F. HeineR.J. SnoekF.J. PouwerF. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis.Diabetologia200649583784510.1007/s00125‑006‑0159‑x 16520921
     [Google Scholar]
  33. HermannsN. KulzerB. KrichbaumM. KubiakT. HaakT. Affective and anxiety disorders in a German sample of diabetic patients: Prevalence, comorbidity and risk factors.Diabet. Med.200522329330010.1111/j.1464‑5491.2005.01414.x 15717877
     [Google Scholar]
  34. de GrootM. AndersonR. FreedlandK.E. ClouseR.E. LustmanP.J. Association of depression and diabetes complications: A meta-analysis.Psychosom. Med.200163461963010.1097/00006842‑200107000‑00015 11485116
     [Google Scholar]
  35. Weijenburg vSKM van Puffelen AL Horn EK More comorbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic.Diabet Med2011281868910.1111/j.1464‑5491.2010.03125.x 21210541
     [Google Scholar]
  36. ScherrerJ.F. XianH. LustmanP.J. A test for common genetic and environmental vulnerability to depression and diabetes.Twin Res. Hum. Genet.201114216917210.1375/twin.14.2.169 21425899
     [Google Scholar]
  37. NanriA. Nutritional epidemiology of type 2 diabetes and depressive symptoms.J. Epidemiol.201323424325010.2188/jea.JE20130018 23748249
     [Google Scholar]
  38. ReisJ.P. LoriaC.M. SorlieP.D. ParkY. HollenbeckA. SchatzkinA. Lifestyle factors and risk for new-onset diabetes: A population-based cohort study.Ann. Intern. Med.2011155529229910.7326/0003‑4819‑155‑5‑201109060‑00006 21893622
     [Google Scholar]
  39. BerkM. SarrisJ. CoulsonC.E. JackaF.N. Lifestyle management of unipolar depression.Acta Psychiatr. Scand.2013127s443385410.1111/acps.12124 23586875
     [Google Scholar]
  40. AlastaloH. RäikkönenK. PesonenA.K. Cardiovascular health of Finnish war evacuees 60 years later.Ann. Med.2009411667210.1080/07853890802301983 18720095
     [Google Scholar]
  41. PesonenA.K. RäikkönenK. HeinonenK. KajantieE. ForsénT. ErikssonJ.G. Depressive symptoms in adults separated from their parents as children: A natural experiment during World War II.Am. J. Epidemiol.2007166101126113310.1093/aje/kwm254 17875582
     [Google Scholar]
  42. AgardhE. AllebeckP. HallqvistJ. Type 2 diabetes incidence and socio-economic position: A systematic review and meta-analysis.Int. J. Epidemiol.201140380481810.1093/ije/dyr029
     [Google Scholar]
  43. GilmanS.E. KawachiI. FitzmauriceG.M. BukaS.L. Socioeconomic status in childhood and the lifetime risk of major depression.Int. J. Epidemiol.200231235936710.1093/ije/31.2.359 11980797
     [Google Scholar]
  44. MenkeA. RustK.F. FradkinJ. ChengY.J. CowieC.C. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: A series of cross-sectional studies.Ann. Intern. Med.2014161532833510.7326/M14‑0286 25178569
     [Google Scholar]
  45. LuppinoF.S. de WitL.M. BouvyP.F. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies.Arch. Gen. Psychiatry201067322022910.1001/archgenpsychiatry.2010.2 20194822
     [Google Scholar]
  46. CharmandariE. TsigosC. ChrousosG. Endocrinology of the stress response.Annu. Rev. Physiol.200567125928410.1146/annurev.physiol.67.040403.120816 15709959
     [Google Scholar]
  47. BlackP.H. Stress and the inflammatory response: A review of neurogenic inflammation.Brain Behav. Immun.200216662265310.1016/S0889‑1591(02)00021‑1 12480495
     [Google Scholar]
  48. ChrousosP. GoldP.W. The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis.JAMA199226791244125210.1001/jama.1992.03480090092034
     [Google Scholar]
  49. ElenkovI.J. WilderR.L. ChrousosG.P. ViziE.S. The sympathetic nerve--an integrative interface between two supersystems: The brain and the immune system.Pharmacol. Rev.2000524595638 11121511
     [Google Scholar]
  50. MaesM. SongC. LinA. The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.Cytokine199810431331810.1006/cyto.1997.0290 9617578
     [Google Scholar]
  51. GoebelM.U. MillsP.J. IrwinM.R. ZieglerM.G. Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: Differential effects and pathways.Psychosom. Med.200062459159810.1097/00006842‑200007000‑00019 10949106
     [Google Scholar]
  52. RaisonC.L. CapuronL. MillerA.H. Cytokines sing the blues: Inflammation and the pathogenesis of depression.Trends Immunol.2006271243110.1016/j.it.2005.11.006 16316783
     [Google Scholar]
  53. GrimbleR.F. Inflammatory status and insulin resistance.Curr. Opin. Clin. Nutr. Metab. Care20025555155910.1097/00075197‑200209000‑00015 12172480
     [Google Scholar]
  54. StringhiniS. BattyG.D. BovetP. Association of lifecourse socioeconomic status with chronic inflammation and type 2 diabetes risk: The Whitehall II prospective cohort study.PLoS Med.2013107e100147910.1371/journal.pmed.1001479 23843750
     [Google Scholar]
  55. BelmakerR.H. AgamG. Major depressive disorder.N. Engl. J. Med.20083581556810.1056/NEJMra073096 18172175
     [Google Scholar]
  56. RotA.H.M. MathewS.J. CharneyD.S. Neurobiological mechanisms in major depressive disorder.CMAJ2009180330531310.1503/cmaj.080697 19188629
     [Google Scholar]
  57. VigH. ApR. TyagiS. RathoreS. WalA. WalP. An insight into the pathogenesis of Diabetic cardiomyopathy along with the novel potential therapeutic approaches.Curr. Diabetes Rev.2023201e020523216416 37138437
     [Google Scholar]
  58. AnismanH. Cascading effects of stressors and inflammatory immune system activation: Implications for major depressive disorder.J. Psychiatry Neurosci.2009341420 19125209
     [Google Scholar]
  59. MyintA.M. KimY.K. Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis.Prog. Neuropsychopharmacol. Biol. Psychiatry20144830431310.1016/j.pnpbp.2013.08.008 24184687
     [Google Scholar]
  60. NeumeisterA. Tryptophan depletion, serotonin, and depression: Where do we stand?Psychopharmacol. Bull.200337499115 15131521
     [Google Scholar]
  61. EngumA. MykletunA. MidthjellK. HolenA. DahlA.A. Depression and Diabetes.Diabetes Care20052881904190910.2337/diacare.28.8.1904 16043730
     [Google Scholar]
  62. ClaudiT. IngskogW. CooperJ.G. JenumA.K. HauskenM.F. Quality of diabetes care in Norwegian general practice.Tidsskr. Nor. Laegeforen.20081282225702574 19023353
     [Google Scholar]
  63. TurnerR. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet1998352913183785310.1016/S0140‑6736(98)07019‑6 9742976
     [Google Scholar]
  64. van HartenB. de LeeuwF.E. WeinsteinH.C. ScheltensP. BiesselsG.J. Brain imaging in patients with diabetes: A systematic review.Diabetes Care200629112539254810.2337/dc06‑1637 17065699
     [Google Scholar]
  65. GoldS.M. DziobekI. SweatV. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes.Diabetologia200750471171910.1007/s00125‑007‑0602‑7 17334649
     [Google Scholar]
  66. KumarA. GuptaR. ThomasA. AjiloreO. HellemannG. Focal subcortical biophysical abnormalities in patients diagnosed with type 2 diabetes and depression.Arch. Gen. Psychiatry200966332433010.1001/archgenpsychiatry.2008.548 19255382
     [Google Scholar]
  67. HoltR.I.G. PhillipsD.I.W. JamesonK.A. CooperC. DennisonE.M. PevelerR.C. The relationship between depression and diabetes mellitus: Findings from the Hertfordshire Cohort Study.Diabet. Med.200926664164810.1111/j.1464‑5491.2009.02742.x 19538241
     [Google Scholar]
  68. RotellaF. MannucciE. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies.Diabetes Res. Clin. Pract.20139929810410.1016/j.diabres.2012.11.022 23265924
     [Google Scholar]
  69. RotellaF. MannucciE. Depression as a risk factor for diabetes: A meta-analysis of longitudinal studies.J. Clin. Psychiatry2013741313710.4088/JCP.12r07922 23419223
     [Google Scholar]
  70. AsgharS. MagnussonA. HussainA. DiepL.M. BhowmikB. ThorsbyP.M. Depression and insulin resistance in non-diabetic subjects: An intervention study with insulin clamp techniqe.Int. J. Clin. Med.20123757558110.4236/ijcm.2012.37104
     [Google Scholar]
  71. BarnardK. PevelerR.C. HoltR.I.G. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: Systematic review.Diabetes Care201336103337334510.2337/dc13‑0560 24065841
     [Google Scholar]
  72. YoonJ.M. ChoE.G. LeeH.K. ParkS.M. Antidepressant use and diabetes mellitus risk: A meta-analysis.Korean J. Fam. Med.201334422824010.4082/kjfm.2013.34.4.228 23904952
     [Google Scholar]
  73. IsaacR. HalfonB.S. GurevitchD. ShainskayaA. LevkovitzY. ZickY. Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.J. Biol. Chem.201328885682569310.1074/jbc.M112.408641 23275337
     [Google Scholar]
  74. LucierJ. WeinstockR.S. Type 1 Diabetes.StatPearls. Treasure Island, FL: StatPearls Publishing2024Available from: https://www.ncbi.nlm.nih.gov/books/NBK507713/
  75. JenaB.N. KalraS. YeravdekarR. Emotional and psychological needs of people with diabetes.Indian J. Endocrinol. Metab.201822569670410.4103/ijem.IJEM_579_17 30294583
     [Google Scholar]
  76. RéusG.Z. dos SantosM.A.B. StrassiA.P. AbelairaH.M. CerettaL.B. QuevedoJ. Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder.Life Sci.2017183788210.1016/j.lfs.2017.06.025 28676432
     [Google Scholar]
  77. AgaçiF. XhardoE. Psychosocial aspects of diabetes mellitus.Int. J. Endocrinol.2020165427431
     [Google Scholar]
  78. LevkovitzY. ShushanB.G. HershkovitzA. Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases.Mol. Cell. Neurosci.200736330531210.1016/j.mcn.2007.05.009 17728140
     [Google Scholar]
  79. HollidayR. Epigenetics: A historical overview.Epigenetics200612768010.4161/epi.1.2.2762 17998809
     [Google Scholar]
  80. JakovljevićM. ReinerZ. MilicićD. CrncevićZ. Comorbidity, multimorbidity and personalized psychosomatic medicine: Epigenetics rolling on the horizon.Psychiatr. Danub.2010222184189 20562744
     [Google Scholar]
  81. NestlerE.J. Epigenetic mechanisms of depression.JAMA Psychiatry201471445445610.1001/jamapsychiatry.2013.4291 24499927
     [Google Scholar]
  82. DayehT. VolkovP. SalöS. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion.PLoS Genet.2014103e100416010.1371/journal.pgen.1004160 24603685
     [Google Scholar]
  83. WangJ. GongB. ZhaoW. Epigenetic mechanisms linking diabetes and synaptic impairments.Diabetes201463264565410.2337/db13‑1063 24154559
     [Google Scholar]
  84. NouwenA. NefsG. CaramlauI. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: A systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium.Diabetes Care201134375276210.2337/dc10‑1414 21357362
     [Google Scholar]
  85. McMartinS.E. JackaF.N. ColmanI. The association between fruit and vegetable consumption and mental health disorders: Evidence from five waves of a national survey of Canadians.Prev. Med.2013563-422523010.1016/j.ypmed.2012.12.016 23295173
     [Google Scholar]
  86. PayneM.E. SteckS.E. GeorgeR.R. SteffensD.C. Fruit, vegetable, and antioxidant intakes are lower in older adults with depression.J. Acad. Nutr. Diet.2012112122022202710.1016/j.jand.2012.08.026 23174689
     [Google Scholar]
  87. WeyererS. Physical inactivity and depression in the community. Evidence from the Upper Bavarian Field Study.Int. J. Sports Med.199213649249610.1055/s‑2007‑1021304 1428382
     [Google Scholar]
  88. GonzalezJ.S. PeyrotM. McCarlL.A. Depression and diabetes treatment nonadherence: A meta-analysis.Diabetes Care200831122398240310.2337/dc08‑1341 19033420
     [Google Scholar]
  89. GonzalezJ.S. SafrenS.A. CaglieroE. Depression, self-care, and medication adherence in type 2 diabetes: Relationships across the full range of symptom severity.Diabetes Care20073092222222710.2337/dc07‑0158 17536067
     [Google Scholar]
  90. LyooI.K. YoonS.J. MusenG. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.Arch. Gen. Psychiatry200966887888710.1001/archgenpsychiatry.2009.86 19652127
     [Google Scholar]
  91. HoN. SommersM.S. LuckiI. Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression.Neurosci. Biobehav. Rev.20133781346136210.1016/j.neubiorev.2013.03.010 23680701
     [Google Scholar]
  92. ChampaneriS. WandG.S. MalhotraS.S. CasagrandeS.S. GoldenS.H. Biological basis of depression in adults with diabetes.Curr. Diab. Rep.201010639640510.1007/s11892‑010‑0148‑9 20878274
     [Google Scholar]
  93. CourtetP. OliéE. Circadian dimension and severity of depression.Eur. Neuropsychopharmacol.2012223S476S48110.1016/j.euroneuro.2012.07.009 22959112
     [Google Scholar]
  94. GangwischJ.E. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism.Obes. Rev.200910s2374510.1111/j.1467‑789X.2009.00663.x 19849800
     [Google Scholar]
  95. DantzerR. O’ConnorJ.C. FreundG.G. JohnsonR.W. KelleyK.W. From inflammation to sickness and depression: When the immune system subjugates the brain.Nat. Rev. Neurosci.200891465610.1038/nrn2297 18073775
     [Google Scholar]
  96. BerendsL.M. OzanneS.E. Early determinants of type-2 diabetes.Best Pract. Res. Clin. Endocrinol. Metab.201226556958010.1016/j.beem.2012.03.002 22980041
     [Google Scholar]
  97. ThompsonC. SyddallH. RodinI. OsmondC. BarkerD.J.P. Birth weight and the risk of depressive disorder in late life.Br. J. Psychiatry2001179545045510.1192/bjp.179.5.450 11689404
     [Google Scholar]
  98. KajantieE. RäikkönenK. Early life predictors of the physiological stress response later in life.Neurosci. Biobehav. Rev.2010351233210.1016/j.neubiorev.2009.11.013 19931557
     [Google Scholar]
  99. ColmanI. AtaullahjanA. NaickerK. LieshoutV.R.J. Birth weight, stress, and symptoms of depression in adolescence: Evidence of fetal programming in a national Canadian cohort.Can. J. Psychiatry201257742242810.1177/070674371205700705 22762297
     [Google Scholar]
  100. VasiliadisH.M. GilmanS.E. BukaS.L. Fetal growth restriction and the development of major depression.Acta Psychiatr. Scand.2008117430631210.1111/j.1600‑0447.2008.01168.x 18321355
     [Google Scholar]
  101. PhillipsD.I.W. Programming of the stress response: A fundamental mechanism underlying the long‐term effects of the fetal environment?J. Intern. Med.2007261545346010.1111/j.1365‑2796.2007.01801.x 17444884
     [Google Scholar]
  102. de VetE. de RidderD.T.D. de WitJ.B.F. Environmental correlates of physical activity and dietary behaviours among young people: A systematic review of reviews.Obes. Rev.2011125e130e14210.1111/j.1467‑789X.2010.00784.x 20630024
     [Google Scholar]
  103. SkinnerM.L. ShirtcliffE.A. HaggertyK.P. CoeC.L. CatalanoR.F. Allostasis model facilitates understanding race differences in the diurnal cortisol rhythm.Dev Psychopathol20112341167118610.1017/S095457941100054X 22018088
     [Google Scholar]
  104. BrennerA.B. ZimmermanM.A. BauermeisterJ.A. CaldwellC.H. The physiological expression of living in disadvantaged neighborhoods for youth.J. Youth Adolesc.201342679280610.1007/s10964‑012‑9838‑8 23086016
     [Google Scholar]
  105. KarbR.A. ElliottM.R. DowdJ.B. MorenoffJ.D. Neighborhood-level stressors, social support, and diurnal patterns of cortisol: The Chicago Community Adult Health Study.Soc. Sci. Med.20127561038104710.1016/j.socscimed.2012.03.031 22698925
     [Google Scholar]
  106. DoD.P. RouxD.A.V. HajatA. Circadian rhythm of cortisol and neighborhood characteristics in a population-based sample: The Multi-Ethnic Study of Atherosclerosis.Health Place201117262563210.1016/j.healthplace.2010.12.019 21292535
     [Google Scholar]
  107. BroylesS.T. StaianoA.E. DrazbaK.T. GuptaA.K. SothernM. KatzmarzykP.T. Elevated C-reactive protein in children from risky neighborhoods: Evidence for a stress pathway linking neighborhoods and inflammation in children.PLoS One201279e4541910.1371/journal.pone.0045419 23049799
     [Google Scholar]
  108. SnoekF.J. VenV.D.N.C.W. TwiskJ.W.R. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: Long‐term effects on HbA1c moderated by depression. A randomized controlled trial.Diabet. Med.200825111337134210.1111/j.1464‑5491.2008.02595.x 19046225
     [Google Scholar]
  109. WinkleyK. LandauS. EislerI. IsmailK. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: Systematic review and meta-analysis of randomised controlled trials.BMJ200633375586510.1136/bmj.38874.652569.55 16803942
     [Google Scholar]
  110. GeorgiadesA. ZuckerN. FriedmanK.E. Changes in depressive symptoms and glycemic control in diabetes mellitus.Psychosom. Med.200769323524110.1097/PSY.0b013e318042588d 17420441
     [Google Scholar]
  111. KorczakD.J. PereiraS. KoulajianK. MatejcekA. GiaccaA. Type 1 diabetes mellitus and major depressive disorder: Evidence for a biological link.Diabetologia201154102483249310.1007/s00125‑011‑2240‑3 21789690
     [Google Scholar]
  112. HoodK.K. LawrenceJ.M. AndersonA. Metabolic and inflammatory links to depression in youth with diabetes.Diabetes Care201235122443244610.2337/dc11‑2329 23033243
     [Google Scholar]
  113. MoultonC.D. CostafredaS.G. HortonP. IsmailK. FuC.H.Y. Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes.Brain Imaging Behav.20159465166210.1007/s11682‑014‑9348‑2 25563229
     [Google Scholar]
  114. DaviesW.A. OwensD. HollandP. HaighD. The effect of parental expressed emotion on glycaemic control in children with Type 1 diabetes.J. Psychosom. Res.200252210711310.1016/S0022‑3999(01)00293‑8 11832256
     [Google Scholar]
  115. LawtonJ. WaughN. BarnardK.D. Challenges of optimizing glycaemic control in children with Type 1 diabetes: A qualitative study of parents’ experiences and views.Diabet. Med.201432810631070 25472898
     [Google Scholar]
  116. ArmstrongB. MackeyE.R. StreisandR. Parenting behavior, child functioning, and health behaviors in preadolescents with type 1 diabetes.J. Pediatr. Psychol.20113691052106110.1093/jpepsy/jsr039 21828111
     [Google Scholar]
  117. SaßmannH. de HairM. DanneT. LangeK. Reducing stress and supporting positive relations in families of young children with type 1 diabetes: A randomized controlled study for evaluating the effects of the DELFIN parenting program.BMC Pediatr.201212115210.1186/1471‑2431‑12‑152 22994843
     [Google Scholar]
  118. GarrettC.J. IsmailK. FonagyP. Understanding developmental psychopathology in Type 1 diabetes through attachment, mentalisation and diabetes distress.Clin. Child Psychol. Psychiatry202126368269410.1177/1359104521994640 33624515
     [Google Scholar]
  119. CiechanowskiP.S. HirschI.B. KatonW.J. Interpersonal predictors of HbA(1c) in patients with type 1 diabetes.Diabetes Care200225473173610.2337/diacare.25.4.731 11919133
     [Google Scholar]
  120. FonagyP. MoranG.S. LindsayM.K. KurtzA.B. BrownR. Psychological adjustment and diabetic control.Arch. Dis. Child.198762101009101310.1136/adc.62.10.1009 3499865
     [Google Scholar]
  121. HoodK.K. RauschJ.R. DolanL.M. Depressive symptoms predict change in glycemic control in adolescents with type 1 diabetes: Rates, magnitude, and moderators of change.Pediatr. Diabetes201112871872310.1111/j.1399‑5448.2011.00771.x 21564454
     [Google Scholar]
  122. LawG.U. WalshJ. QueraltV. NouwenA. Adolescent and parent diabetes distress in type 1 diabetes: The role of self-efficacy, perceived consequences, family responsibility and adolescent–parent discrepancies.J. Psychosom. Res.201374433433910.1016/j.jpsychores.2012.12.009 23497836
     [Google Scholar]
  123. FrierBM Living with hypoglycaemia.Hypoglycaemia in Clinical Diabetes.Chichester, UK: John Wiley and Sons2007230933210.1002/9780470516270.ch14
     [Google Scholar]
  124. GreyM. BolandE.A. DavidsonM. LiJ. TamborlaneW.V. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life.J. Pediatr.2000137110711310.1067/mpd.2000.106568 10891831
     [Google Scholar]
  125. MurphyH.R. RaymanG. SkinnerT.C. Psycho‐educational interventions for children and young people with Type 1 diabetes.Diabet. Med.200623993594310.1111/j.1464‑5491.2006.01816.x 16922699
     [Google Scholar]
  126. TsiouliE. AlexopoulosE.C. StefanakiC. DarviriC. ChrousosG.P. Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes: Systematic review.Can. Fam. Physician2013592143149 23418238
     [Google Scholar]
  127. van SchaaijkM.N.M. VersteeghR.A.B.C. van BaarA.L. The interrelationships among paternal and maternal parenting stress, metabolic control, and depressive symptoms in adolescents with type 1 diabetes mellitus.J. Pediatr. Psychol.2013381304010.1093/jpepsy/jss096 22988060
     [Google Scholar]
  128. MillerD. CarltonB.S. The etiology and treatment of anorexia nervosa.Adolesc. Psychiatry198512219232 4003680
     [Google Scholar]
  129. PowersM.A. RichterS. AckardD. GerkenS. MeierM. CriegoA. Characteristics of persons with an eating disorder and type 1 diabetes and psychological comparisons with persons with an eating disorder and no diabetes.Int. J. Eat. Disord.201245225225610.1002/eat.20928 21495056
     [Google Scholar]
  130. ColtonP.A. OlmstedM.P. DanemanD. RodinG.M. Depression, disturbed eating behavior, and metabolic control in teenage girls with type 1 diabetes.Pediatr. Diabetes201314537237610.1111/pedi.12016 23418901
     [Google Scholar]
  131. CorathersS.D. KichlerJ. JonesN.H.Y. Improving depression screening for adolescents with type 1 diabetes.Pediatrics20131325e1395e140210.1542/peds.2013‑0681 24127480
     [Google Scholar]
  132. ZduńczykB. SendelaJ. SzypowskaA. High prevalence of depressive symptoms in well‐controlled adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.Diabetes Metab. Res. Rev.201430433333810.1002/dmrr.2499 24323887
     [Google Scholar]
  133. JohnsonB. EiserC. YoungV. BrierleyS. HellerS. Prevalence of depression among young people with Type 1 diabetes: A systematic review.Diabet. Med.201330219920810.1111/j.1464‑5491.2012.03721.x 22698387
     [Google Scholar]
  134. StrandbergR.B. GraueM. LarsenW.T. PeyrotM. RokneB. Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes.J. Psychosom. Res.201477317417910.1016/j.jpsychores.2014.06.015 25149027
     [Google Scholar]
  135. TriefP.M. XingD. FosterN.C. Depression in Adults in the T1D Exchange Clinic Registry.Diabetes Care20143761563157210.2337/dc13‑1867 24855157
     [Google Scholar]
  136. CampayoA. de JongeP. RoyJ.F. Depressive disorder and incident diabetes mellitus: The effect of characteristics of depression.Am. J. Psychiatry2010167558058810.1176/appi.ajp.2009.09010038 20123914
     [Google Scholar]
  137. SambamoorthiU. MaY. FindleyP.A. Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries.J. Diabetes201353327335 23173757
     [Google Scholar]
  138. RennB.N. FelicianoL. SegalD.L. The bidirectional relationship of depression and diabetes: A systematic review.Clin. Psychol. Rev.20113181239124610.1016/j.cpr.2011.08.001 21963669
     [Google Scholar]
  139. KanC. SilvaN. GoldenS.H. A systematic review and meta-analysis of the association between depression and insulin resistance.Diabetes Care201336248048910.2337/dc12‑1442 23349152
     [Google Scholar]
  140. KilpatrickE.S. RigbyA.S. AtkinS.L. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “Double diabetes” in the diabetes control and complications trial.Diabetes Care2007303707712
     [Google Scholar]
  141. KatonW. RussoJ. LinE.H.B. Diabetes and poor disease control: Is comorbid depression associated with poor medication adherence or lack of treatment intensification?Psychosom. Med.200971996597210.1097/PSY.0b013e3181bd8f55 19834047
     [Google Scholar]
  142. AndersohnF. SchadeR. SuissaS. GarbeE. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.Am. J. Psychiatry2009166559159810.1176/appi.ajp.2008.08071065 19339356
     [Google Scholar]
  143. DeuschleM. Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults.Curr. Opin. Psychiatry2013261606510.1097/YCO.0b013e32835a4206 23187087
     [Google Scholar]
  144. GoldneyR.D. PhillipsP.J. FisherL.J. WilsonD.H. Diabetes, depression, and quality of life: A population study.Diabetes Care20042751066107010.2337/diacare.27.5.1066 15111522
     [Google Scholar]
  145. JacobsonA.M. de GrootM. SamsonJ.A. The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus.Qual. Life Res.199761112010.1023/A:1026487509852 9062437
     [Google Scholar]
  146. BrielerJ.A. SalasJ. GarrettK.E. ScherrerJ.F. Achievement of glycemic control and antidepressant medication use in comorbid depression and type 2 diabetes.J. Affect. Disord.20233243241710.1016/j.jad.2022.12.066 36566931
     [Google Scholar]
  147. LudmanE.J. KatonW. RussoJ. Depression and diabetes symptom burden.Gen. Hosp. Psychiatry200426643043610.1016/j.genhosppsych.2004.08.010 15567208
     [Google Scholar]
  148. LustmanP.J. AndersonR.J. FreedlandK.E. de GrootM. CarneyR.M. ClouseR.E. Depression and poor glycemic control: A meta-analytic review of the literature.Diabetes Care200023793494210.2337/diacare.23.7.934 10895843
     [Google Scholar]
  149. HislopA.L. FeganP.G. SchlaeppiM.J. DuckM. YeapB.B. Prevalence and associations of psychological distress in young adults with Type 1 diabetes.Diabet. Med.2008251919610.1111/j.1464‑5491.2007.02310.x 18199136
     [Google Scholar]
  150. AikensJ.E. PerkinsD.W. PietteJ.D. LiptonB. Association between depression and concurrent Type 2 diabetes outcomes varies by diabetes regimen.Diabet. Med.200825111324132910.1111/j.1464‑5491.2008.02590.x 19046223
     [Google Scholar]
  151. WuC.S. HsuL.Y. WangS.H. Association of depression and diabetes complications and mortality: A population-based cohort study.Epidemiol. Psychiatr. Sci.202029e9610.1017/S2045796020000049 31992379
     [Google Scholar]
  152. O’ConnorP.J. NarayanK.M.V. AndersonR. Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: The ACCORD trial.Diabetes Care20123571479148110.2337/dc11‑1868 22584134
     [Google Scholar]
  153. RobinsL.N. WingJ. WittchenH.U. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures.Arch. Gen. Psychiatry198845121069107710.1001/archpsyc.1988.01800360017003 2848472
     [Google Scholar]
  154. AmorimP. LecrubierY. WeillerE. HerguetaT. SheehanD. DSM-IH-R psychotic disorders: Procedural validity of the mini international neuropsychiatric interview (MINI). Concordance and causes for discordance with the CIDI.Eur. Psychiatry1998131263410.1016/S0924‑9338(97)86748‑X 19698595
     [Google Scholar]
  155. HoltR.I.G. CornelisF.C.M. Key concepts in screening for depression in people with diabetes.J. Affect. Disord.2012142S72S7910.1016/S0165‑0327(12)70011‑3 23062860
     [Google Scholar]
  156. RoyT. LloydC.E. PouwerF. HoltR.I.G. SartoriusN. Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: A systematic review.Diabet. Med.201229216417510.1111/j.1464‑5491.2011.03401.x 21824180
     [Google Scholar]
  157. BeckA.T. WardC.H. MendelsonM. MockJ. ErbaughJ. An inventory for measuring depression.Arch. Gen. Psychiatry19614656157110.1001/archpsyc.1961.01710120031004 13688369
     [Google Scholar]
  158. RadloffL.S. The CES-D Scale.Appl. Psychol. Meas.19771338540110.1177/014662167700100306
     [Google Scholar]
  159. KroenkeK. SpitzerR.L. WilliamsJ.B.W. LöweB. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review.Gen. Hosp. Psychiatry201032434535910.1016/j.genhosppsych.2010.03.006 20633738
     [Google Scholar]
  160. ZigmondA.S. SnaithR.P. The hospital anxiety and depression scale.Acta Psychiatr. Scand.198367636137010.1111/j.1600‑0447.1983.tb09716.x 6880820
     [Google Scholar]
  161. WeijenburgS.K.M. de VroegeL. PloegerR.R. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics.BMC Health Serv. Res.201010123510.1186/1472‑6963‑10‑235 20704720
     [Google Scholar]
  162. WhooleyM.A. AvinsA.L. MirandaJ. BrownerW.S. Case-finding instruments for depression.J. Gen. Intern. Med.199712743944510.1046/j.1525‑1497.1997.00076.x 9229283
     [Google Scholar]
  163. PouwerF. TackC.J. DuijvestijnG.P.H.L.M. Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: A randomised controlled trial.Diabetologia201154474174810.1007/s00125‑010‑2033‑0 21221528
     [Google Scholar]
  164. GilbodyS. SheldonT. HouseA. Screening and case-finding instruments for depression: A meta-analysis.CMAJ20081788997100310.1503/cmaj.070281 18390942
     [Google Scholar]
  165. CornelisF.C.M. NuyenJ. StoopC. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: A systematic review and meta-analysis.Gen. Hosp. Psychiatry201032438039510.1016/j.genhosppsych.2010.03.011 20633742
     [Google Scholar]
  166. LustmanP.J. GriffithL.S. FreedlandK.E. KisselS.S. ClouseR.E. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial.Ann. Intern. Med.1998129861362110.7326/0003‑4819‑129‑8‑199810150‑00005 9786808
     [Google Scholar]
  167. KatonW.J. KorffV.M. LinE.H.B. The Pathways Study: A randomized trial of collaborative care in patients with diabetes and depression.Arch. Gen. Psychiatry200461101042104910.1001/archpsyc.61.10.1042 15466678
     [Google Scholar]
  168. van BastelaarK.M.P. PouwerF. CuijpersP. RiperH. SnoekF.J. Web-based depression treatment for type 1 and type 2 diabetic patients: A randomized, controlled trial.Diabetes Care201134232032510.2337/dc10‑1248 21216855
     [Google Scholar]
  169. CornelisF.C. Comorbid diabetes and depression: Do E-health treatments achieve better diabetes control?Diabetes Manag.20133537938810.2217/dmt.13.37
     [Google Scholar]
  170. LustmanP.J. GriffithL.S. ClouseR.E. Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial.Psychosom. Med.199759324125010.1097/00006842‑199705000‑00007 9178335
     [Google Scholar]
  171. LustmanP.J. FreedlandK.E. GriffithL.S. ClouseR.E. Fluoxetine for depression in diabetes: A randomized double-blind placebo-controlled trial.Diabetes Care200023561862310.2337/diacare.23.5.618 10834419
     [Google Scholar]
  172. GülserenL. GülserenS. HekimsoyZ. MeteL. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients.Arch. Med. Res.200536215916510.1016/j.arcmed.2004.12.018 15847950
     [Google Scholar]
  173. KhazaieH. RahimiM. TatariF. RezaeiM. NajafiF. TahmasianM. Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?Neurosciences20111614245 21206443
     [Google Scholar]
  174. LustmanP.J. WilliamsM.M. SayukG.S. NixB.D. ClouseR.E. Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion.Diabetes Care200730345946610.2337/dc06‑1769 17327305
     [Google Scholar]
  175. GoodnickP.J. KumarA. HenryJ.H. BukiV.M. GoldbergR.B. Sertraline in coexisting major depression and diabetes mellitus.Psychopharmacol. Bull.1997332261264 9230640
     [Google Scholar]
  176. WilliamsM.M. ClouseR.E. NixB.D. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes.Diabetes Care200730480180610.2337/dc06‑1825 17392541
     [Google Scholar]
  177. AmsterdamJ.D. ShultsJ. RutherfordN. SchwartzS. Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus.Neuropsychobiology200654420821410.1159/000100369 17337914
     [Google Scholar]
  178. WilleS.M. CooremanS.G. NeelsH.M. Relevant issues in the monitoring and the toxicology of antidepressants.Crit. Rev. Clin. Lab. Sci.2008451258910.1080/10408360701713112
     [Google Scholar]
  179. SerrettiA. MandelliL. Antidepressants and body weight: A comprehensive review and meta-analysis.J. Clin. Psychiatry201071101259127210.4088/JCP.09r05346blu 21062615
     [Google Scholar]
  180. SayukG.S. GottB.M. NixB.D. LustmanP.J. Improvement in sexual functioning in patients with type 2 diabetes and depression treated with bupropion.Diabetes Care201134233233410.2337/dc10‑1714 21270190
     [Google Scholar]
  181. NihtiläE.K. MartikainenP.T. KoskinenS.V. Chronic conditions and the risk of long-term institutionalization among older people.Eur. J. Public Health2008181778410.1093/eurpub/ckm025
     [Google Scholar]
  182. MitchellA.J. MaloneD. DoebbelingC.C. Quality of medical care for people with and without comorbid mental illness and substance misuse: Systematic review of comparative studies.Br. J. Psychiatry2009194649149910.1192/bjp.bp.107.045732 19478286
     [Google Scholar]
  183. LawrenceD. CoghlanR. Health inequalities and the health needs of people with mental illness.N. S. W. Public Health Bull.200213715515810.1071/NB02063 12451410
     [Google Scholar]
  184. FrayneS.M. HalanychJ.H. MillerD.R. Disparities in diabetes care: Impact of mental illness.Arch. Intern. Med.2005165222631263810.1001/archinte.165.22.2631 16344421
     [Google Scholar]
  185. KatonW.J. LinE.H.B. KorffV.M. Collaborative care for patients with depression and chronic illnesses.N. Engl. J. Med.2010363272611262010.1056/NEJMoa1003955 21190455
     [Google Scholar]
  186. MolosankweI. PatelA. GagliardinoJ.J. KnappM. McDaidD. Economic aspects of the association between diabetes and depression: A systematic review.J. Affect. Disord.2012142S42S5510.1016/S0165‑0327(12)70008‑3 23062857
     [Google Scholar]
  187. SimonG.E. KatonW.J. LinE.H.B. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.Arch. Gen. Psychiatry2007641657210.1001/archpsyc.64.1.65 17199056
     [Google Scholar]
  188. KatonW. UnützerJ. FanM.Y. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.Diabetes Care200629226527010.2337/diacare.29.02.06.dc05‑1572 16443871
     [Google Scholar]
  189. HayJ.W. KatonW.J. EllK. LeeP.J. GutermanJ.J. Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes.Value Health201215224925410.1016/j.jval.2011.09.008 22433755
     [Google Scholar]
  190. NicholsonT.R.J. TaylorJ.P. GosdenC. TrigwellP. IsmailK. National guidelines for psychological care in diabetes: How mindful have we been?Diabet. Med.200926444745010.1111/j.1464‑5491.2009.02701.x 19388977
     [Google Scholar]
/content/journals/cdr/10.2174/0115733998288090240509105717
Loading
Comorbidity of Depression and Diabetes: A Literature Review on Systemic Flaws in Healthcare and the Benefits of Collaborative Diagnosis and Treatment in Primary Care Settings
Curr. Diabetes Rev. 21, E240524230295 (2025); https://doi.org/10.2174/0115733998288090240509105717
/content/journals/cdr/10.2174/0115733998288090240509105717
/content/journals/cdr/10.2174/0115733998288090240509105717
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): comorbidity; depression; Diabetes; epidemiology; prevalence; risk factors

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test